Legal Note
Contact Us
Site Map
Home Page
Dexel
  • About Us
    • Overview
    • Mission
    • Manufacturing Facilities
    • Executive Team
  • Our Products
  • Research
    • Innovative
    • Generic
    • Patented Technologies
    • In-House Facilities
    • Future Products
  • Global Activities
    • General
    • Manufacture & Supply
    • Laboratory Facilities
  • Activities in Israel
    • General
    • Sales and Marketing in Israel
  • Affiliates
    • United Kingdom
    • Germany
    • United States
  • Careers
    • Israel
    • United Kingdom
    • Germany
    • Available Positions
Patented Technologies

Search Site:

Search
Research & Development
Innovative
Generic
Patented Technologies
In-House Facilities
Future Products

Patented Technologies

Patented Technologies
28/01/2009

Dexcel Pharma has invented core, proprietary, patent-protected drug delivery technologies:


Zero Neutralized Delayed Release (ZNDR)
Reversible neutralized enteric coating. Resistance at full acid pH range – no protective sub-coat required.
  • GI therapeutic areas, such as Omepradex® and Omepradex-Z® (generic to Prilosec® and Prilosec OTC®).
  • Tablets/capsules marketed in the US, UK, Israel, Australia and Singapore.

Periodontal Pocket Delivery System (PerioChip®)
Local release of antiseptic agent using unique biodegradable matrix.

  • Marketed to dentists in the US (NDA), 12 EU member states and Singapore, soon to be launched in Korea.


Preconcentrate Technology (PT)
Soft gelatin capsules filled with liquid containing insoluble drugs.

  • Deximune® Ciclosporine (generic to Neoral Sandimmune®).
  • Marketed in Israel, the UK, Germany, the Netherlands, Denmark and Bosnia-Herzegovina, soon to be launched in other countries.

Coated Extended Release Technology (CERT)
Extended-release tablet-coating formulation, comprising specific mixture of polymers surrounding controlled-release core.

  • ViePax® XR Venlafaxine (generic to Effexor® XR).
  • Marketed in Israel, the UK, Germany, the Netherlands, Greece, Portugal and Singapore.


Biodegradable Polymers
A line of products, based on biodegradable polymers, for the treatment of various infections at target locations in the body, with improved efficacy and safety over injectables.


Time-Controlled Delivery System (TCDS®)
Unique delivery technology providing time-controlled release, in tablets and capsules, independent of pH and enzymes in the GI system, for burst and extended release in single or double pulses.

  • Increased bioavailability, efficacy and safety.
  • Extended, controlled GI site absorption.
  • Independent of pH, fluid viscosity, and GI agitation rate.


Fast Dissolving Microsphere-Based Tablets

  • Unique compressible multi-unit system.
  • Designed for fast dissolving, with delayed-release profile.
Print
Home Page | Site Map | Contact Us | Legal Note
© All Rights Reserved to Dexcel Ltd.
Another site by | Graphic Design OneGroup | Developed by CodeOasis |